The use of embryonic stem cells for regulatory developmental toxicity testing in vitro -: The current status of test development

被引:63
作者
Bremer, S [1 ]
Hartung, T [1 ]
机构
[1] Commiss European Communities, Inst Hlth & Consumer Protect, Joint Res Ctr, ECVAM, I-21020 Ispra, VA, Italy
关键词
embryonic stem cells; developmental toxicity; alternative method; chemical policy; test strategy;
D O I
10.2174/1381612043383700
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The future chemical policy of the European Union as well as the 7th amendment of the cosmetic directive is calling for the development of alternative tests to animal experimentation for toxicological safety testing. In the field of embryotoxicity one or the most promising in vitro models are based on embryonic stein cells. The embryonic stem cell test has already been validated in comparison to in vivo results in an international blind collaboration study. The presented review is discussing the use, limitations and further needs for the test in order to be fully suitable for regulatory acceptance. In this context, it is summarized which requirements for an in vitro embryotoxicity test have to be fulfilled for regulatory toxicity testing. In addition, an overview about the Current status of test development of other embryonic stem cell tests is presented. Several workshops have reviewed the progress of in vitro tests for developmental toxicity testing. A general consensus Of these workshops has been that one single test will not be sufficient to cover all manifestations of developmental toxicity. The establishment of a test battery for developmental toxicity is required. This will be even more challenging since the principles of a composing test strategy and its validation have not been defined yet. Finally, the unique possibility of combining the human embryonic stem cell technology and the microarray techniques might lead to a deeper understanding of the toxicological mechanisms of human developmental toxicants.
引用
收藏
页码:2733 / 2747
页数:15
相关论文
共 106 条
  • [11] BIGOT K, 1999, ATLA-ALTERN LAB ANIM, V27, P291
  • [12] Genetic toxicities of human teratogens
    Bishop, JB
    Witt, KL
    Sloane, RA
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1997, 396 (1-2) : 9 - 43
  • [13] Bremer S, 1997, EUR J CELL BIOL, V74, P26
  • [14] Detection of the embryotoxic potential of cyclophosphamide by using a combined system of metabolic competent cells and embryonic stem cells
    Bremer, S
    Pellizzer, C
    Coecke, S
    Paparella, M
    Catalani, P
    [J]. ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2002, 30 (01): : 77 - 85
  • [15] Establishment of an in vitro reporter gene assay for developmental cardiac toxicity
    Bremer, S
    Worth, AP
    Paparella, M
    Bigot, K
    Kolossov, E
    Fleischmann, BK
    Hescheler, J
    Balls, M
    [J]. TOXICOLOGY IN VITRO, 2001, 15 (03) : 215 - 223
  • [16] Effects of embryotoxic chemicals on the in vitro differentiation of genetically engineered embryonic stem cells into cardiac cells
    Bremer, S
    Van Dooren, M
    Paparella, M
    Kossolov, E
    Fleischmann, BK
    Hescheler, J
    [J]. TOXICOLOGY IN VITRO, 1999, 13 (4-5) : 645 - 650
  • [17] Factors relating to readmission of term and near term neonates in the first two weeks of life
    Brown, AK
    Damus, K
    Kim, MH
    King, K
    Harper, R
    Campbell, D
    Crowley, KA
    Lakhani, M
    Cohen-Addad, N
    Kim, R
    Harin, A
    [J]. JOURNAL OF PERINATAL MEDICINE, 1999, 27 (04) : 263 - 275
  • [18] Brown NA, 1995, ATLA-ALTERN LAB ANIM, V23, P868
  • [19] Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests
    Brown, NA
    [J]. ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2002, 30 (02): : 177 - 198
  • [20] BROWN NA, 1987, ARCH TOXICOL, P105